IFITM1 and infection: Herein, we observed no significant change in the mRNA expression profiles of the antiviral ISGs MX1 and IFITM1 during secondary H3N2 infection nor HRV-A16 re-infection as compared to their respective single infections in hNECs (Figure 3A,B).